OptimizeRx Q4 EPS $0.23 Beats $0.20 Estimate, Sales $20.30M Beat $20.16M Estimate

OptimizeRx (NASDAQ:OPRX) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.20 by 15 percent. This is a 43.75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $20.30 million which beat the analyst consensus estimate of $20.16 million by 0.69 percent. This is a 23.58 percent increase over sales of $16.43 million the same period last year.